Status:
RECRUITING
Continuous Glucose Monitoring and OGTT Screen for Cystic Fibrosis Related Diabetes in Cystic Fibrosis
Lead Sponsor:
Medical College of Wisconsin
Conditions:
Cystic Fibrosis-related Diabetes
Cystic Fibrosis
Eligibility:
All Genders
18+ years
Brief Summary
Cystic Fibrosis (CF) related diabetes (CFRD) is a unique form of diabetes mellitus, different from type 1 diabetes and type 2 diabetes. The diagnosis of CFRD is associated with a decline in pulmonary ...
Detailed Description
Research design and methods * Clinic will continue to follow CFF standard of care guidelines. Subjects will complete the annual OGTT and an annual HgbA1c. * Sample Dexcom G7 Sensors will be provided ...
Eligibility Criteria
Inclusion
- An adult patient, diagnosed with CF, established with Froedtert Multidisciplinary CF Clinic.
- Normal glucose tolerance or impaired glucose tolerance per OGTT completed in 2024.
- At healthy baseline status at time of CGM wear and OGTT.
Exclusion
- Diagnosed with CFRD and treating with diabetogenic medications.
- s/p transplant
- pregnancy
- failure to wear CGM for entirety of 10 days
Key Trial Info
Start Date :
January 13 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 30 2026
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06560463
Start Date
January 13 2025
End Date
September 30 2026
Last Update
September 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Medical College of Wisconsin
Milwaukee, Wisconsin, United States, 53226